Bioactive lead compounds and molecular targets for the treatment of heart diseases

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorEzzat, Shahira M
dc.contributor.authorSalama, Maha M
dc.contributor.authorSalem, Mohamed A.
dc.date.accessioned2021-02-09T07:49:35Z
dc.date.available2021-02-09T07:49:35Z
dc.date.issued2020-01-02
dc.description.abstractHeart diseases are the major reasons for mortality and disability around the world. One of the leading causes of heart diseases is the chronic proatherogenic inflammation that may lead to further acute complications. Epidemiological studies have shown a marked association between hypercholesterolemia, hypertension, diabetes, inflammatory mediators, oxidative stress, and heart diseases. In recent decades, alternative and complementary medicines, especially herbal medicine and nutraceuticals, have been excessively evaluated for treating various heart diseases. Many researches have studied the impact of the strong antioxidant activities of some medicinal plants on serum lipid level and consequently on the development of atherosclerosis and ischemia. For instance, natural products such as resveratrol, berberine, and curcumin, which are proved to possess antioxidant, antiinflammatory, and autophagy-modulating activities, are reported to be potential in treating heart diseases. This chapter provided an overview about the importance of natural products in modern medicine as a source of novel lead compounds that can be beneficial in treating heart disease through acting on different molecular targets.en_US
dc.identifier.citationEzzat, S. M., Salama, M. M., & Salem, M. A. (2020). Bioactive lead compounds and molecular targets for the treatment of heart diseases. Phytochemicals as Lead Compounds for New Drug Discovery, 67–94. https://doi.org/10.1016/b978-0-12-817890-4.00005-6 ‌
dc.identifier.doihttps://doi.org/10.1016/B978-0-12-817890-4.00005-6
dc.identifier.otherhttps://doi.org/10.1016/B978-0-12-817890-4.00005-6
dc.identifier.urihttp://repository.msa.edu.eg/xmlui/handle/123456789/4423
dc.language.isoen_USen_US
dc.publisherELSEVIER en_US
dc.relation.ispartofseriesPHYTOCHEMICALS AS LEAD COMPOUNDS FOR NEW DRUG DISCOVERY;2020, Pages 67-94
dc.subjectENDOPLASMIC-RETICULUM STRESSen_US
dc.subjectPREVENTS ENDOTHELIAL DYSFUNCTIONen_US
dc.subjectPOLYUNSATURATED FATTY-ACIDSen_US
dc.subjectREDUCES BLOOD-PRESSUREen_US
dc.subjectNF-KAPPA-Ben_US
dc.subjectANGIOTENSIN-CONVERTING ENZYMEen_US
dc.subjectCARDIOVASCULAR RISK-FACTORSen_US
dc.subjectNADPH OXIDASE ACTIVATIONen_US
dc.subjectOXIDATIVE STRESSen_US
dc.subjectNITRIC-OXIDEen_US
dc.titleBioactive lead compounds and molecular targets for the treatment of heart diseasesen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ezzat2020.pdf
Size:
742.48 KB
Format:
Adobe Portable Document Format
Description: